One More Gene Therapy Approved Before Year’s End – American Council on Science and Health
American Council on Science and Health |
One More Gene Therapy Approved Before Year’s End
American Council on Science and Health One more gene therapy squeaked in before year’s end, not for cancer treatment, but an inherited form of vision loss that can lead to blindness called biallelic RPE65 mutation-associated retinal dystrophy. The treatment is called Luxturna (voretigene … |
|
CAR T-cell therapies in treating lymphoma: Pros and cons
ModernMedicine Catherine Bollard, MD, director of the Center for Cancer and Immunology Research at Washington, D.C.-based Children’s National Health System, discussed immunotherapy for non-Hodgkin’s lymphoma at the 2017 American Society of Hematology (ASH) annual … |
Medical News Bulletin |
Cancer Immunotherapy Treatment Hits a Hurdle
Medical News Bulletin Cancer immunotherapy has recently seen some great advancements and a lot of hope lies in this treatment approach. Cancer immunotherapy is a type of therapy approach that uses the body’s own immune system to target and fight off cancer. This type of … Immunotherapy: The next frontier in cancer treatment | afr.comThe Australian Financial Review |
WIRED |
Crispr Isn’t Enough Any More. Get Ready for Gene Editing 2.0
WIRED In fewer than five years, the gene-editing technology known as Crispr has revolutionized the face and pace of modern biology. Since its ability to find, remove, and replace genetic material was first reported in 2012, scientists have published more … Bioethicist discusses possibilities, pitfalls of gene editingDuluth News Tribune |
The Australian Financial Review |
Immunotherapy: The next frontier in cancer treatment
The Australian Financial Review This is where immunotherapy started and, while scientists have been trying to work out where it fits, it has been leapfrogging forward and is now used as a first-line treatment for melanoma and a second line for lung, bladder and kidney cancer. It’s … Thousands given hope in cancer care revolutionThe Times |
The Australian Financial Review |
Immunotherapy: The next frontier in cancer treatment
The Australian Financial Review This is where immunotherapy started and, while scientists have been trying to work out where it fits, it has been leapfrogging forward and is now used as a first-line treatment for melanoma and a second line for lung, bladder and kidney cancer. It’s … Thousands given hope in cancer care revolutionThe Times |